ArticleAddiction (Abingdon, England)2014
Towards a comprehensive developmental model of cannabis use disorders.
Article in Addiction (Abingdon, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Concurrent validity of the marijuana purchase task: a meta-analysis of trait-level cannabis demand and cannabis involvement.Addiction (Abingdon, England) · 2023Pooled it
- Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review.International journal of environmental research and public health · 2020Pooled it
- Predicting the geographical distribution of drug use disorder in Sweden from the geographical variation in social deprivation, genetic risk and urbanization.Molecular psychiatry · 2026Article
- Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study.Molecular psychiatry · 2025Article
- The Youth Risk Index: psychometrics, predicting the initiation of early adolescent substance use, and the breadth of liability detected.Frontiers in child and adolescent psychiatry · 2025Article
- The geographical distribution of the family-genetic risk score for drug use disorder in Sweden and its co-localization with areas of social deprivation.Psychological medicine · 2024Article
- Substance Use Disorders: Population Prevention.Focus (American Psychiatric Publishing) · 2024Article
- Vulnerable Populations and Substance Use Prevention Service Delivery for the Mental Health Professional.Focus (American Psychiatric Publishing) · 2024Review
- Cannabis Use and Sharing Practices Among Sexual Minority and Heterosexual Individuals During the COVID-19 Pandemic.LGBT health · 2023Article
- Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2023Article
- The economic impact of cannabis use disorder and dementia diagnosis in veterans diagnosed with traumatic brain injury.Frontiers in neurology · 2023Article
- 3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2022Article
- Differences in child and adult biopsychosocial characteristics associated with regular cannabis use in individuals with and without cannabis use disorder.Drug and alcohol dependence · 2021Article
- Which came first: Cannabis use or deficits in impulse control?Progress in neuro-psychopharmacology & biological psychiatry · 2021Review
- Drug use disorder following early life exposure to tetrachloroethylene (PCE)-contaminated drinking water: a retrospective cohort study.Environmental health : a global access science source · 2020Article
- Emotion Dysregulation Moderates the Association Between Stress and Problematic Cannabis Use.Frontiers in psychiatry · 2020Article
- Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder.The American journal of psychiatry · 2019Article
- Dysregulation as a correlate of cannabis use and problem use.Addictive behaviors · 2019Article
- Cannabis and the Current State of Treatment for Cannabis Use Disorder.Focus (American Psychiatric Publishing) · 2019Article
- The Changing Landscape of Substance Use Disorders.Focus (American Psychiatric Publishing) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsTo develop a comprehensive risk-factor model of cannabis use disorders (CUD) based on Kendler's development model for major depression.
designRisk factors were divided into five developmental tiers based on Kendler's model of depression (childhood, early adolescence, late adolescence, adulthood, past year). Hierarchical logistic regression models were used to examine the independent contribution of each risk factor. Separate models were built to predict the lifetime risk of cannabis use and the risk of CUD among those with a history of lifetime risk of cannabis use.
settingData were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) in the United States.
participantsParticipants consisted of wave 2 of the NESARC (n = 34 653). MEASUREMENTS: Odds ratios (OR), Adjusted OR (AOR) and confidence intervals (95% CI) were used to determine the risk factors in each tier and with multiple models.
findingsAfter mutually adjusting for the effect of other risk factors, lifetime history of drug use disorder (AOR = 4.78, 95% CI = 1.53-14.91), past year alcohol use disorders (AOR = 6.55, 95% CI = 2.54-16.89) and independent (AOR = 1.57, 95% CI = 1.15-2.14) and dependent (AOR = 1.25, 95% CI = 1.01-1.55) stressful life events predicted lifetime cannabis use. Impulsivity (AOR = 2.18, 95% CI = 1.34-3.53), past year alcohol use disorders (AOR = 4.09, 95% CI = 2.29-7.31), greater number of Axis I disorders (AOR = 1.56, 95% CI = 1.01-2.40) and social deviance (AOR = 1.19, 95% CI = 1.08-1.32) independently increased the risk of the development of CUD, whereas religious service attendance (AOR = 0.50, 95% CI = 0.30-0.85) decreased this risk. In both models, the effect of earlier development tiers was mediated by more proximal ones. There were few gender differences in both models.
conclusionsA modification of Kendler's risk factor model for major depression which stratifies risk factors into five groups (childhood, early adolescence, late adolescence, adulthood, past year) provides a useful foundation for a comprehensive developmental model of cannabis use and cannabis use disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.